Resmed Inc (RMD) Stock Price, Quote & News

Company Profile

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry,...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 858-836-5000

Website: www.resmed.com

Address:

9001 Spectrum Center Boulevard, San Diego, United States

Washingtonstate May. 1 at 6:47 PM

$RMD

1 · Reply

macdub8 May. 1 at 3:26 PM

$IXHL another 1.5b wiped off $RMD market cap in the space of 1.5hours today Anyway this is going to be the last post about RMD and IXHL. I truly believe that bigger things are awaiting IXHL.

2 · Reply

thefourpercent May. 1 at 3:15 PM

$RMD eyes are here too, waiting

0 · Reply

Anonymouspapertrader Apr. 30 at 10:29 PM

$RMD 100sma still in trend, 200sma still not in the trend, so it looks to be a test of the 100 here.

0 · Reply

Mamalama Apr. 30 at 9:39 PM

$IXHL $RMD and that’s a no

0 · Reply

macdub8 Apr. 30 at 9:17 PM

$RMD $IXHL RMD is absolutely nose-diving in AH. Nearly 2b of its market cap wiped in an hour.

3 · Reply

StocktwitsEarnings Apr. 30 at 8:14 PM

$RMD Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $2.74 up 10.04% YoY • Reported revenue of $1.43B up 10.81% YoY • As Resmed advances through the remainder of fiscal year 2026, the company remains focused on expanding access to care globally, scaling digital health capabilities, and delivering further strong, profitable growth.

0 · Reply

_Rocket Apr. 30 at 8:09 PM

$RMD $IXHL announce the buyout immediately you cucks. Nobody cares about how your quarter went. We want disclosure.

2 · Reply

J4y000 Apr. 30 at 8:03 PM

$RMD -> $IXHL

0 · Reply

Rvvrn9 Apr. 30 at 7:06 PM

$IXHL $RMD AH before EC

0 · Reply

ResMed beats quarterly profit estimates, names new CFO

Apr 30, 2026, 4:30 PM EDT - 4 days ago

ResMed Earnings Call Transcript: Q3 2026

Apr 30, 2026, 4:10 PM EDT - 4 days ago

Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor

Apr 30, 2026, 4:05 PM EDT - 4 days ago

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026

Apr 1, 2026, 4:05 PM EDT - 4 weeks ago

Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026

Mar 3, 2026, 3:00 AM EST - 2 months ago

Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach

Feb 25, 2026, 12:56 PM EST - 2 months ago

ResMed At $250: Missed Opportunity Or A Trap In The Making?

Feb 24, 2026, 9:00 AM EST - 2 months ago

Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana

Feb 3, 2026, 12:29 AM EST - 3 months ago

Sleep device maker ResMed ramps up doctor outreach to tap Ozempic surge

NVO

Jan 30, 2026, 1:08 PM EST - 3 months ago

Analysts Maintain Bull Case On ResMed Despite Competition Concerns

Jan 29, 2026, 4:41 PM EST - 3 months ago

ResMed beats quarterly profit estimates on strong demand for its sleep devices

Jan 29, 2026, 4:30 PM EST - 3 months ago

ResMed Earnings Call Transcript: Q2 2026

Jan 29, 2026, 4:05 PM EST - 3 months ago

Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026

Jan 12, 2026, 1:30 PM EST - 4 months ago

ResMed Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 8, 2026, 4:05 PM EST - 4 months ago

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026

Dec 18, 2025, 4:05 PM EST - 4 months ago

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

Dec 8, 2025, 9:00 AM EST - 5 months ago

Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy

Nov 24, 2025, 2:15 PM EST - 5 months ago

IDEXX Laboratories Vs ResMed: Which Stock Could Rally?

IDXX

Nov 19, 2025, 6:00 PM EST - 5 months ago

ResMed Transcript: AGM 2025

Oct 31, 2025, 9:24 AM EDT - 6 months ago

These Analysts Revise Their Forecasts On ResMed Following Q1 Results

Oct 30, 2025, 4:30 PM EDT - 6 months ago

ResMed Earnings Call Transcript: Q1 2026

Oct 30, 2025, 4:05 PM EDT - 6 months ago

Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026

Oct 9, 2025, 4:05 PM EDT - 7 months ago

Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025

Sep 23, 2025, 8:20 AM EDT - 7 months ago

ResMed Transcript: Bank of America Global Healthcare Conference 2025

Sep 16, 2025, 4:05 PM EDT - 8 months ago

Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025

Sep 8, 2025, 9:00 PM EDT - 8 months ago

The sleep economy is 'having a moment', says medical equipment firm Resmed

Sep 3, 2025, 4:15 PM EDT - 8 months ago

Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority

Aug 27, 2025, 9:00 AM EDT - 8 months ago

Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds

Aug 18, 2025, 4:15 PM EDT - 9 months ago

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

Aug 1, 2025, 2:16 PM EDT - 9 months ago

ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings

Jul 31, 2025, 4:53 PM EDT - 9 months ago

Resmed beats quarterly profit estimates on strong demand for sleep devices

Jul 31, 2025, 4:30 PM EDT - 9 months ago

ResMed Earnings Call Transcript: Q4 2025

Jul 31, 2025, 4:05 PM EDT - 9 months ago

Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025

Jul 30, 2025, 6:08 AM EDT - 9 months ago

Spot Outliers Like ResMed Early with Money Flows

Jul 1, 2025, 4:05 PM EDT - 10 months ago

Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025

May 15, 2025, 9:00 AM EDT - 1 year ago

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025

May 1, 2025, 9:00 AM EDT - 1 year ago

Resmed Acquires VirtuOx

Apr 24, 2025, 3:24 PM EDT - 1 year ago

ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast

Apr 23, 2025, 5:08 PM EDT - 1 year ago

ResMed slightly beats quarterly profit estimates on sleep devices demand

Apr 23, 2025, 4:30 PM EDT - 1 year ago

ResMed Earnings Call Transcript: Q3 2025

Apr 23, 2025, 4:05 PM EDT - 1 year ago

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

Apr 21, 2025, 5:00 PM EDT - 1 year ago

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Apr 3, 2025, 9:00 AM EDT - 1 year ago

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

Apr 2, 2025, 4:05 PM EDT - 1 year ago

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

Mar 19, 2025, 8:00 AM EDT - 1 year ago

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

Mar 11, 2025, 9:00 AM EDT - 1 year ago

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

Feb 26, 2025, 3:00 AM EST - 1 year ago

ResMed's Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

Feb 11, 2025, 4:30 AM EST - 1 year ago

Jan De Witte joins GHO Capital as Operating Partner

IART

Feb 3, 2025, 12:59 PM EST - 1 year ago

Stock Of The Day: Trading The Range In ResMed

Jan 30, 2025, 5:21 PM EST - 1 year ago

ResMed beats quarterly profit estimates on demand for sleep disorder devices

Jan 30, 2025, 4:30 PM EST - 1 year ago

ResMed Earnings Call Transcript: Q2 2025

Jan 30, 2025, 4:05 PM EST - 1 year ago

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025

Jan 13, 2025, 6:00 PM EST - 1 year ago

ResMed Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 9, 2025, 4:05 PM EST - 1 year ago

ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025

Jan 6, 2025, 4:05 PM EST - 1 year ago

ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 23, 2024, 2:59 PM EST - 1 year ago

Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

INSP LLY

Dec 4, 2024, 4:13 AM EST - 1 year ago

Canada Sleep Apnea Devices Market Research Report 2024: Opportunities and Forecasts to 2029 Featuring Braebon Medical, VitalAire, FPM Solutions, SomnoMed, and ResMed

Nov 12, 2024, 6:30 PM EST - 1 year ago

ResMed Transcript: UBS Global Healthcare Conference 2024

Nov 5, 2024, 4:05 PM EST - 1 year ago

ResMed Announces Participation in the UBS Global Healthcare Conference

Oct 29, 2024, 11:23 AM EDT - 1 year ago

ResMed CEO On Earnings, Sleep Apnea

Oct 25, 2024, 11:15 AM EDT - 1 year ago

Sleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says Analyst

Washingtonstate May. 1 at 6:47 PM

$RMD

1 · Reply

macdub8 May. 1 at 3:26 PM

$IXHL another 1.5b wiped off $RMD market cap in the space of 1.5hours today Anyway this is going to be the last post about RMD and IXHL. I truly believe that bigger things are awaiting IXHL.

2 · Reply

thefourpercent May. 1 at 3:15 PM

$RMD eyes are here too, waiting

0 · Reply

Anonymouspapertrader Apr. 30 at 10:29 PM

$RMD 100sma still in trend, 200sma still not in the trend, so it looks to be a test of the 100 here.

0 · Reply

Mamalama Apr. 30 at 9:39 PM

$IXHL $RMD and that’s a no

0 · Reply

macdub8 Apr. 30 at 9:17 PM

$RMD $IXHL RMD is absolutely nose-diving in AH. Nearly 2b of its market cap wiped in an hour.

3 · Reply

StocktwitsEarnings Apr. 30 at 8:14 PM

0 · Reply

_Rocket Apr. 30 at 8:09 PM

$RMD $IXHL announce the buyout immediately you cucks. Nobody cares about how your quarter went. We want disclosure.

2 · Reply

J4y000 Apr. 30 at 8:03 PM

$RMD -> $IXHL

0 · Reply

Rvvrn9 Apr. 30 at 7:06 PM

$IXHL $RMD AH before EC

0 · Reply

DonCorleone77 Apr. 30 at 6:56 PM

$RBLX $RMD $MTZ $RDDT $DXCM Some notable companies reporting after the market close, with earnings consensus Estimates: - Apple (AAPL), consensus $1.95 - Amgen (AMGN), consensus $4.77 - SandDisk (SNDK), consensus $14.62 - Western Digital (WDC), consensus $2.40 - Stryker (SYK), consensus $2.98 - Roblox (RBLX), consensus (41c) - Resmed (RMD), consensus $2.80 - MasTec (MTZ), consensus 99c - Reddit (RDDT), consensus 57c - Dexcom (DXCM), consensus 47c - Twilio (TWLO), consensus $1.27 - First Solar (FSLR), consensus $3.03 - Rivian (RIVN), consensus (63c) - Atlassian (TEAM), consensus $1.33 - Illumina (ILMN), consensus $1.06 - Roku (ROKU), consensus 33c - Clorox (CLX), consensus $1.55 - Boston Beer (SAM), consensus $1.97 - Five9 (FIVN), consensus 68c.

0 · Reply

macdub8 Apr. 30 at 5:41 PM

$IXHL $RMD good time to regurgitate this from October 2025. A tuck in acquisition is exactly what IXHL would be..to its very core. Lets see

0 · Reply

Estimize Apr. 30 at 3:00 PM

$RMD reports after the close, Estimize Consensus -0.01 EPS and +3.39M Revs compared to WS http://www.estimize.com/rmd/fq3-2026?utm_content=

0 · Reply

Rasputi Apr. 30 at 1:06 PM

$IXHL $RMD one year ago, listen Mick Farrell about GOP and how his machines are the gold standard. Stock pumped till August then dramatically down since. We will see if his 100% bet on tuck-in tech/AI acquisition keep the road… Start the video at 2:04 https://www.youtube.com/watch?v=WOfr1jBSCXo

0 · Reply

J4y000 Apr. 30 at 12:36 PM

$RMD -> $IXHL One way or another RMD suffers if they don’t act soon and either BO or Partner.

0 · Reply

IldijanaMM Apr. 30 at 12:33 PM

$IXHL $RMD They need us! Just saying 😉

0 · Reply

stockro1 Apr. 30 at 12:25 PM

$IXHL $RMD earnings report today. Let’s see.

0 · Reply

macdub8 Apr. 30 at 11:47 AM

$RMD $IXHL Couldnt agree more. RMD has more to lose however as IXHL has a lot more other avenues. RMD has had $13B of its market cap wiped since August alone. Its staggering. I.e. its lost 260x the value of IXHL in the space of 8 months.

0 · Reply

macdub8 Apr. 30 at 7:15 AM

$IXHL Jesus $RMD is free-falling. Down 30% from August. Millions wiped. And contuinung.

1 · Reply

RocketCityRetai1 Apr. 29 at 3:06 PM

$IXHL $RMD this actually interest me a little. I think RMD is less likely to partner with us than Jazz or Novo, I’ll say that first. But, with the RMD insider sells, it makes me wonder if they plan to build a pharmaceutical arm to the company. Knowing that it will cost many millions, do insiders want to reposition after that happens and SP stabilizes. Nothing to support this, it crossed my mind a few months ago.

0 · Reply

Michaelthoaicaonguyen Apr. 29 at 3:03 PM

$IXHL well according to @eyeexaechell we are not getting a BO from $RMD Lilly have Zepbound Novo just partner with HIMs Who’s left??

2 · Reply

Chapman211 Apr. 29 at 1:55 PM

$IXHL $RMD looks like they are on the same sinking ship as us. Down 22% ($61.50) in 2.5 month.

1 · Reply

Market Cap	29.87B
Revenue (ttm)	5.15B
Net Income (ttm)	1.40B
EPS (ttm)	N/A
PE Ratio	19.85
Forward PE	19.35
Profit Margin	27.22%
Debt to Equity Ratio	0.06

Volume	2,483,617
Avg Vol	1,079,216
Day's Range	N/A - N/A
Shares Out	145.68M
Stochastic %K	22%
Beta	0.85
Analysts	Sell
Price Target	$277.85